128 related articles for article (PubMed ID: 26126695)
1. Sarcomatoid Carcinoma of the Prostate: Retrospective Review of a Case Series From the Johns Hopkins Hospital.
Markowski MC; Eisenberger MA; Zahurak M; Epstein JI; Paller CJ
Urology; 2015 Sep; 86(3):539-43. PubMed ID: 26126695
[TBL] [Abstract][Full Text] [Related]
2. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
[TBL] [Abstract][Full Text] [Related]
4. Sarcomatoid carcinoma of the prostate: a study of 42 cases.
Hansel DE; Epstein JI
Am J Surg Pathol; 2006 Oct; 30(10):1316-21. PubMed ID: 17001164
[TBL] [Abstract][Full Text] [Related]
5. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
Culp SH; Schellhammer PF; Williams MB
Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
[TBL] [Abstract][Full Text] [Related]
6. Does repeat biopsy affect the prognosis of patients with prostate cancer treated with radical prostatectomy? Analysis by the number of cores taken at initial biopsy.
Park M; You D; Yoon JH; Jeong IG; Song C; Hong JH; Ahn H; Kim CS
BJU Int; 2012 May; 109(10):1474-9. PubMed ID: 21933324
[TBL] [Abstract][Full Text] [Related]
7. 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.
Mitchell CR; Boorjian SA; Umbreit EC; Rangel LJ; Carlson RE; Karnes RJ
BJU Int; 2012 Dec; 110(11):1709-13. PubMed ID: 22934913
[TBL] [Abstract][Full Text] [Related]
8. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
D'Amico AV; Hui-Chen M; Renshaw AA; Sussman B; Roehl KA; Catalona WJ
J Urol; 2006 Dec; 176(6 Pt 2):S11-5. PubMed ID: 17084157
[TBL] [Abstract][Full Text] [Related]
9. Complications and outcomes of salvage robot-assisted radical prostatectomy: a single-institution experience.
Yuh B; Ruel N; Muldrew S; Mejia R; Novara G; Kawachi M; Wilson T
BJU Int; 2014 May; 113(5):769-76. PubMed ID: 24314031
[TBL] [Abstract][Full Text] [Related]
10. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases.
Lopez-Beltran A; Pacelli A; Rothenberg HJ; Wollan PC; Zincke H; Blute ML; Bostwick DG
J Urol; 1998 May; 159(5):1497-503. PubMed ID: 9554341
[TBL] [Abstract][Full Text] [Related]
11. Prostate sarcomatoid carcinoma as accidental finding in transurethral resection of prostate specimen. A case report and systematic review of current literature.
Stamatiou K; Galariotis N; Olympitis M; Papadopoulos P; Moschouris H; Lambrakopoulos A
G Chir; 2011; 32(1-2):23-8. PubMed ID: 21352703
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.
Thompson IM; Tangen CM; Paradelo J; Lucia MS; Miller G; Troyer D; Messing E; Forman J; Chin J; Swanson G; Canby-Hagino E; Crawford ED
JAMA; 2006 Nov; 296(19):2329-35. PubMed ID: 17105795
[TBL] [Abstract][Full Text] [Related]
13. Sarcomatoid Carcinoma of the Prostate Presenting in a 44 Year Old.
Conroy M; Greally M; MacEneaney O; O’Keane C; McCaffrey J
Ir Med J; 2018 Oct; 111(9):825. PubMed ID: 30556673
[TBL] [Abstract][Full Text] [Related]
14. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
Johnson SB; Hamstra DA; Jackson WC; Zhou J; Foster B; Foster C; Song Y; Li D; Palapattu GS; Kunju L; Mehra R; Sandler H; Feng FY
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):275-81. PubMed ID: 23886418
[TBL] [Abstract][Full Text] [Related]
15. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
16. A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score.
Fine SW; Epstein JI
J Urol; 2008 Apr; 179(4):1335-8; discussion 1338-9. PubMed ID: 18289601
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer.
Prayer-Galetti T; Sacco E; Pagano F; Gardiman M; Cisternino A; Betto G; Sperandio P
BJU Int; 2007 Aug; 100(2):274-80. PubMed ID: 17355369
[TBL] [Abstract][Full Text] [Related]
18. Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis.
Briganti A; Karnes RJ; Da Pozzo LF; Cozzarini C; Capitanio U; Gallina A; Suardi N; Bianchi M; Tutolo M; Salonia A; Di Muzio N; Rigatti P; Montorsi F; Blute M
Eur Urol; 2011 May; 59(5):832-40. PubMed ID: 21354694
[TBL] [Abstract][Full Text] [Related]
19. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
Karram S; Trock BJ; Netto GJ; Epstein JI
Am J Surg Pathol; 2011 Sep; 35(9):1351-5. PubMed ID: 21836493
[TBL] [Abstract][Full Text] [Related]
20. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
